• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Azithromycin does not increase hematologic relapse in pediatric hematopoietic cell transplant recipients.

作者信息

Sabulski Anthony, Wallace Gregory, Lane Adam, Davies Stella M, Myers Kasiani C

机构信息

Division of Bone Marrow Transplantation and Immune Deficiency, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.

Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.

出版信息

Bone Marrow Transplant. 2022 Oct;57(10):1589-1591. doi: 10.1038/s41409-022-01746-y. Epub 2022 Jul 1.

DOI:10.1038/s41409-022-01746-y
PMID:35778608
Abstract
摘要

相似文献

1
Azithromycin does not increase hematologic relapse in pediatric hematopoietic cell transplant recipients.阿奇霉素不会增加小儿造血细胞移植受者的血液学复发率。
Bone Marrow Transplant. 2022 Oct;57(10):1589-1591. doi: 10.1038/s41409-022-01746-y. Epub 2022 Jul 1.
2
Azithromycin may increase hematologic relapse rates in matched unrelated donor hematopoietic cell transplant recipients who receive anti-thymocyte globulin, but not in most other recipients.阿奇霉素可能会增加接受抗胸腺细胞球蛋白的匹配无关供体造血细胞移植受者的血液学复发率，但在大多数其他受者中则不会。
Bone Marrow Transplant. 2021 Mar;56(3):745-748. doi: 10.1038/s41409-020-01073-0. Epub 2020 Oct 2.
3
Effect of Azithromycin on Airflow Decline-Free Survival After Allogeneic Hematopoietic Stem Cell Transplant: The ALLOZITHRO Randomized Clinical Trial.阿奇霉素对异基因造血干细胞移植后无气流下降生存期的影响：ALLOZITHRO随机临床试验
JAMA. 2017 Aug 8;318(6):557-566. doi: 10.1001/jama.2017.9938.
4
Palliative care of hematopoietic cell transplant recipients and families.造血干细胞移植受者及其家属的姑息治疗。
Semin Oncol Nurs. 2014 Nov;30(4):253-61. doi: 10.1016/j.soncn.2014.08.007.
5
Incidence, Risk Factors, and Outcomes of Chronic Graft-versus-Host Disease in Pediatric Patients with Hematologic Malignancies after T Cell-Replete Myeloablative Haploidentical Hematopoietic Stem Cell Transplantation with Antithymocyte Globulin/Granulocyte Colony-Stimulating Factor.T 细胞富含的清髓性半相合造血干细胞移植联合抗胸腺细胞球蛋白/粒细胞集落刺激因子后，血液系统恶性肿瘤患儿发生慢性移植物抗宿主病的发生率、风险因素和结局。
Biol Blood Marrow Transplant. 2020 Sep;26(9):1655-1662. doi: 10.1016/j.bbmt.2020.05.021. Epub 2020 Jun 3.
6
Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation.阿奇霉素通过破坏异基因干细胞移植后的免疫和代谢网络促进复发。
Blood. 2022 Dec 8;140(23):2500-2513. doi: 10.1182/blood.2022016926.
7
Unrelated Donor Transplant Recipients Given Thymoglobuline Have Superior GRFS When Compared to Matched Related Donor Recipients Undergoing Transplantation without ATG.与未用 ATG 的匹配相关供者移植受者相比，接受胸腺球蛋白的无关供者移植受者具有更好的 GRFS。
Biol Blood Marrow Transplant. 2020 Oct;26(10):1868-1875. doi: 10.1016/j.bbmt.2020.06.030. Epub 2020 Jul 5.
8
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.异基因反应性作为血液系统恶性肿瘤治疗的治疗原则。非清髓性预处理的异基因造血细胞移植的临床和免疫学方面的研究。
Dan Med Bull. 2007 May;54(2):112-39.
9
Fludarabine and melphalan-based conditioning for patients with advanced hematological malignancies relapsing after a previous hematopoietic stem cell transplant.对于先前造血干细胞移植后复发的晚期血液系统恶性肿瘤患者，采用氟达拉滨和美法仑进行预处理。
Bone Marrow Transplant. 2001 Sep;28(6):557-62. doi: 10.1038/sj.bmt.1703198.
10
Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival.与双脐带移植相比，减低强度单倍体加单脐带移植：植入改善，无移植物抗宿主病，无复发生存率提高。
Haematologica. 2016 May;101(5):634-43. doi: 10.3324/haematol.2015.138594. Epub 2016 Feb 11.